LYON JOSEPH DOUGLAS (Chief Accounting Officer) sold 44.5% of their position (5K shares) of CORCEPT THERAPEUTICS INC on the open market
Open‑market sale worth $325.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/29/2026ACC: 0001193125-26-248977
Officer· Chief Accounting Officer
Since Jul 2020
-5K
Net shares
Net seller
$325.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5K
Price / share
$65.00
Trade value
$325K
% of position
44.5%
5/27/2026
11.23K→6.23K
Total
Net shares
−5K
Net value
-$325K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/27/2026 | S · Sale | −5K | $65.00 | $325K | 44.5% | 11.23K | 6.23K |
| Total | −5K | -$325K | ||||||
Derivative Transactions0
No derivative transactions reported